Delivery Order HHSN261201700007I-75N91021F00001
Award Date 9/20/21
Potential Completion Date 9/19/26
Potential Value $3.2M
Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
Total Small Business
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed Pricing Type
Cost Plus Fixed Fee
Place of Performance
Alachua, FL 32615, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a $6,092,489.45 cost-plus-fixed-fee contract awarded by the National Cancer Institute (NCI), a civilian agency within the National Institutes of Health (NIH), to Alchem Laboratories Corporation, a small business manufacturer based in Alachua, Florida. The contract is for the non-GMP (non-good manufacturing practice) synthesis of compounds to support NCI's drug development efforts. The contract has a period of performance through September 19, 2021. Alchem Laboratories is also the...
- The National Cancer Institute issued a delivery order to Alchem Laboratories Corporation on June 5, 2022, with a ceiling value of $2,332,902 for synthesis of non-GMP small molecules and cGMP synthesis of small molecules for drug development. The order is set aside for small business and carries a cost-plus-fixed-fee pricing structure. Place of performance is Alachua, FL. The ultimate completion date is June 4, 2027. The work encompasses incremental synthesis of non-GMP small molecule samples and...
- The National Cancer Institute awarded a definitive contract to Alchem Laboratories Corporation for synthesis of non-GMP small molecules on May 21, 2012, under a total small business set-aside, with a ceiling value of $7,542,381.41. The originating solicitation covers synthesis of non-GMP small molecules for Work Assignment 1. Place of performance is Alachua, FL. The period of performance runs from May 21, 2012 through May 20, 2017, with ultimate completion on July 7, 2017. The contract is priced...
- This is a $5,623,209.67 cost-plus-award-fee contract awarded by the National Cancer Institute to Alchem Laboratories Corporation, a for-profit pharmaceutical manufacturer in Alachua, Florida. The contract is for the synthesis of non-GMP small molecule samples to support the National Cancer Institute's research. It has an ultimate completion date of September 30, 2012. Alchem Laboratories is also an awardee on several indefinite delivery vehicle (IDV) contracts with the National Cancer...
- The National Cancer Institute awarded a $42,941.42 delivery order to Alchem Laboratories Corporation for the non-Good Manufacturing Practice (non-GMP) synthesis of 100 grams of (R)-N-(6-chloro-4-((1-phenylethyl)amino)pyrido[3,4-d]pyrimidin-5-yl)methanesulfonamide (MTX-531), a small molecule compound. The contract was awarded on July 22, 2022, with an ultimate completion date of October 21, 2022, under a cost-plus-fixed-fee pricing structure. This award was designated as a Total Small Business...
- The National Cancer Institute awarded a $2.86 million definitive contract to Alchem Laboratories Corporation for manufacture of bulk chemicals and bulk pharmaceutical ingredients for preclinical and clinical studies on August 1, 2017, under a total small business set-aside. The contract is cost-plus-fixed-fee and supports the FY26 UDO Initiative. Place of performance is Alachua, FL. The ultimate completion date is June 4, 2022. Service Contract Inventory data reflects actual government invoicing...
- Alchem Laboratories Corporation, doing business as Alchem Laboratories Corp., has been awarded a $17,148.47 delivery order against the Preclinical Services for HIV Therapeutics master indefinite-delivery/indefinite-quantity (IDIQ) contract by the National Institutes of Health's National Institute of Allergy and Infectious Diseases. The purpose of this task order is for Alchem Laboratories to develop and deliver a quality assurance/quality control plan and participate in a task order initiation...
- This federal contract award is for the purchase of 10 grams and 1 kilogram of high purity meta cresol purple sodium salt, awarded to Alchem Laboratories Corporation, a for-profit manufacturer based in Alachua, Florida. The $80,000 firm fixed-price contract was awarded by the National Institute of Standards and Technology (NIST), a civilian federal agency, on September 29, 2016 with an ultimate completion date of October 31, 2017. No small business set-aside was used for this award. Alchem...
- The National Institute on Drug Abuse awarded a $101,000 firm fixed-price purchase order to Chemogenics Biopharma, LLC on September 16, 2025, for synthesis and bioanalytical analysis services supporting the National Center for Advancing Translational Sciences (NCATS) Early Translational Branch Chemistry Program. The contract, which extends through July 15, 2026, is performable in Durham, North Carolina. This procurement does not utilize a small business set-aside designation. The work involves...
- The National Cancer Institute issued a $35,252.94 delivery order to Sri International on February 24, 2020, under the NIH Analysis of Anti-Cancer Chemicals 2017-2022 IDIQ for release analysis of anti-cancer drug bulk lots. The order covers analytical chemistry work including appearance assessment, polymorphic form determination, infrared spectroscopy, high-performance liquid chromatography assay and impurity analysis, moisture determination, residual solvent testing, refractive index...